Inequalities in time to cancer treatment initiation over a decade in Brazil
DOI:
https://doi.org/10.11606/s1518-8787.2026060006943Palavras-chave:
Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Treatment Delay, Sociodemographic Factors, Health Inequities, Health Status DisparitiesResumo
OBJECTIVE: To evaluate access to treatment for cervical (CVC), colorectal (CRC), thyroid (CT), and central nervous system (CCNS) cancers that differ in incidence, prognosis, early detection program, and in their requirements for high-complexity and technologically advanced treatments
METHODS: Data from IntegradorRHC INCA (2013–2022) were extracted. Sociodemographic and clinic characteristics and time diagnosis-to-treatment were analyzed using multinomial logistic regression and cumulative incidence function.
RESULTS: 395,225 cases of cancers were identified, CC = 168,951, CVC = 141,189, CT = 57,755 and CCNS = 27,330. Patients with CNS and CRC had higher cumulative probability (CPob) of treatment initiation within 60 days compared to CVC/CT. The North region was less likely to receive treatment within 30 days for all cancers (odds ratio — OR: CNS = 0.34; CVC = 0.30; CT = 0.17; CRC = 0.49). Radiotherapy showed a lower chance of earlier treatment for all cancers (94% lower CNS; CVC = 48%; CRC = 81%). There was a greater chance of treatment initiation within 30 days for patients with higher education for CVC (OR = 1.42); CT (OR = 2.09). White individuals demonstrated a consistently higher CPob of treatment initiation at 60 days for all cancers compared to Black (CNS: 60 versus 49%; CVC: 37 versus 29%; CT: 32 versus 21%; CRC: 52 versus 45%). For CT, males had a higher CPob of treatment 37% in males compared to 30% in females at 60 days). For CRC, CPob of treatment initiation at 60 days was higher among individuals at younger (60% compared to 46% for those aged > 69 years) and clinical stage IV (56% compared to stage 1 — 45%).
CONCLUSION: In Brazil, patients requiring multimodal treatments or therapies demanding technology, such as radiotherapy or chemotherapy, faced longer delays. Regional and sociodemographic disparities persist, with timely access to cancer treatment limited in socioeconomically disadvantaged regions, such as the North and Northeast, among Black patients and individuals with lower education.
Referências
1. Landmann-Szwarcwald C, Macinko J. A panorama of health inequalities in Brazil. Int J Equity Health. 2016;15(1):174. https://doi.org/10.1186/s12939-016-0462-1
2. Fantom N, Serajuddin U. The World Bank’s Classification of Countries by Income [Internet]. 2016 [accessed December 8, 2024]. Available from: http://econ.worldbank.org
3. Nunes BP, Thumé E, Tomasi E, Duro SM, Facchini LA. Socioeconomic inequalities in the access to and quality of health care services. Rev Saúde Pública. 2014;48(6):968-76. https://doi.org/10.1590/S0034-8910.2014048005388
4. Marmot M, Allen JJ. Social determinants of health equity. Am J Public Health. 2014;104(Suppl. 4):S517-9. https://doi.org/10.2105/AJPH.2014.302200
5. Brasil. Constituição da República Federativa do Brasil. Diário Oficial da União [Internet]. 1988 [accessed December 10, 2024]. Available from: https://www.planalto.gov.br/ccivil_03/constituicao/constituicao.htm
6. Brasil. Lei nº 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início. Diário Oficial da União [Internet]. 2012 [accessed December 10, 2024]. Available from: https://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm
7. Atty A, Tomazelli J. Relatório do intervalo entre diagnóstico e início do tratamento do câncer no SUS [Internet]. Rio de Janeiro: Ministério da Saúde, Secretaria de Atenção à Saúde, Instituto Nacional de Câncer José Alencar Gomes da Silva; 2020 [accessed December 15, 2024]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//relatorio_painel_oncologia_sus_maio2020.pdf
8. Lima MAN, Villela DAM. Sociodemographic and clinical factors associated with time to treatment for colorectal cancer in Brazil, 2006-2015. Cad Saúde Pública. 2021;37(5):e00214919. https://doi.org/10.1590/0102-311X00214919
9. Brasil. Incidência de Câncer no Brasil: estimativa 2023 [Internet]. Instituto Nacional do Câncer; 2022 [accessed December 16, 2024]. Available from: https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document//estimativa-2023.pdf
10. Horbinski C, Nabors LB, Portnow J, Baehring J, Bhatia A, Bloch O, et al. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022. J Natl Compr Canc Netw. 2023;21(1):12-20. https://doi.org/10.6004/jnccn.2023.0002
11. Schiffman JD, Fisher PG, Gibbs P. Early detection of cancer: past, present, and future. Am Soc Clin Oncol Educ Book. 2015;35:57-65. https://doi.org/10.14694/EdBook_AM.2015.35.57
12. Fitzgerald RC, Antoniou AC, Fruk L, Rosenfeld N. The future of early cancer detection. Nat Med. 2022;28(4):666-77. https://doi.org/10.1038/s41591-022-01746-x
13. Castelo M, Paszat L, Hansen BE, Scheer AS, Faught N, Nguyen L, et al. Comparing time to diagnosis and treatment between younger and older adults with colorectal cancer: a population-based study. Gastroenterology. 2023;164(7):1152-64. https://doi.org/10.1053/j.gastro.2023.02.024
14. Helsper CCW, van Erp NNF, Peeters PPHM, de Wit NNJ. Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement? Eur J Cancer. 2017;87:113-21. https://doi.org/10.1016/j.ejca.2017.10.003
15. Kaltenmeier C, Shen C, Medich DS, Geller DA, Bartlett DL, Tsung A, et al. Time to surgery and colon cancer survival in the United States. Ann Surg. 2021;274(6):1025-31. https://doi.org/10.1097/SLA.0000000000003745
16. Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, et al. Time to initial cancer treatment in the United States and association with survival over time: An observational study. PLoS One. 2019;14(3):e0213209. https://doi.org/10.1371/journal.pone.0213209
17. Kowkabany G, Jimenez PB, Sharan S, Bansal S, Ahmed SH, Raikot S, et al. Inequities in time to treat thyroid cancer. Anticancer Res. 2023;43(11):5025-30. https://doi.org/10.21873/anticanres.16701
18. Silva IF, da Silva IF, Saraceni V, Koifman RJ. Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country. Cancer Epidemiol. 2023;86:102450. https://doi.org/10.1016/j.canep.2023.102450
19. Silva DRM, Fernandes GA, França e Silva ILA, Curado MP. Cancer stage and time from cancer diagnosis to first treatment during the COVID-19 pandemic. Semin Oncol. 2023;50(1-2):60-5. https://doi.org/10.1053/j.seminoncol.2023.03.005
20. Silva DS, Pinto MC, Figueiredo MAA. Factors associated with delay in specialized treatment after diagnosis of cervical cancer in Bahia State, Brazil. Cad Saúde Pública. 2022;38(5):e00022421. https://doi.org/10.1590/0102-311XPT022421
21. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Detecção precoce do câncer [Internet]. Rio de Janeiro: INCA; 2023 [accessed June 26, 2025]. Available from: https://www.inca.gov.br/publicacoes/livros/deteccao-precoce-do-cancer
22. Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683-91. https://doi.org/10.1136/gutjnl-2015-310912
23. Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan P, et al. Stage at diagnosis and colorectal cancer survival in six high-income countries: a population-based study of patients diagnosed during 2000-2007. Acta Oncol. 2013;52(5):919-32. https://doi.org/10.3109/0284186X.2013.764008
24. Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264-72. https://doi.org/10.1016/S2213-8587(22)00035-3
25. Bryant JM, Doniparthi A, Weygand J, Cruz-Chamorro R, Oraiqat IM, Andreozzi J, et al. Treatment of central nervous system tumors on combination MR-linear accelerators: review of current practice and future directions. Cancers (Basel). 2023;15(21):5200. https://doi.org/10.3390/cancers15215200
26. Brasil. Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Integrador de Registros Hospitalares de Câncer (IRHC) – RHCNet [Internet]. Rio de Janeiro: INCA [accessed December 10, 2024]. Available from: https://irhc.inca.gov.br/RHCNet/
27. Forma A, Kłodnicka K, Pająk W, Flieger J, Teresińska B, Januszewski J, et al. Thyroid cancer: epidemiology, classification, risk factors, diagnostic and prognostic markers, and current treatment strategies. Int J Mol Sci. 2025;26(11):5173. https://doi.org/10.3390/ijms26115173
28. Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087. https://doi.org/10.1136/bmj.m4087
29. Malta DC, Bernal RT, de Souza MF, Szwarcwald CL, Lima MG, Barros MB. Social inequalities in the prevalence of self-reported chronic non-communicable diseases in Brazil: national health survey 2013. Int J Equity Health. 2016;15(1):153. https://doi.org/10.1186/s12939-016-0427-4
30. Castelo M, Sue-Chue-Lam C, Paszat L, Kishibe T, Scheer AS, Hansen BE, et al. Time to diagnosis and treatment in younger adults with colorectal cancer: A systematic review. PLoS One. 2022;17(9):e0273396. https://doi.org/10.1371/journal.pone.0273396
31. Patel P, De P. Trends in colorectal cancer incidence and related lifestyle risk factors in 15-49-year-olds in Canada, 1969-2010. Cancer Epidemiol. 2016;42:90-100. https://doi.org/10.1016/j.canep.2016.03.009
32. Davis ME. Epidemiology and overview of gliomas. Semin Oncol Nurs. 2018;34(5):420-9. https://doi.org/10.1016/j.soncn.2018.10.001
33. Vogel JD, Felder SI, Bhama AR, Hawkins AT, Langenfeld SJ, Shaffer VO, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Colon Cancer. Dis Colon Rectum. 2022;65(2):148-77. https://doi.org/10.1097/DCR.0000000000002323
34. Serventi J, Behr J. Surgery and evidence-based treatments in patients with newly diagnosed high-grade glioma. Semin Oncol Nurs. 2018;34(5):443-53. https://doi.org/10.1016/j.soncn.2018.10.009
35. Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. JAMA. 2024;331(5):425-35. https://doi.org/10.1001/jama.2023.26348
Publicado
Edição
Seção
Licença
Direitos autorais (c) 2026 Matheus de Abreu, Maria Emília Mota, Dandara Menezes de Araujo Oliveira, Yuri de Lima Medeiros, Maria Stella Moreira, Fábio Abreu Alves, Maria Paula Curado
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
